UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549

                                   FORM 10-QSB

(x)   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003

( )   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

     For the transition period from __________________TO __________________

                         Commission File Number 0-29057

                          ALTRIMEGA HEALTH CORPORATION
               (Exact name of registrant as specified in charter)

             NEVADA                                     87-0631750
             ------                                     ----------
 (State or other jurisdiction of                (I.R.S. Employer I.D. No.)
 incorporation or organization)

   4702 OLEANDER DRIVE, SUITE 200, MYRTLE BEACH, SC              29577
   ------------------------------------------------              -----
           (Address of principal executive offices)              (Zip)

    Issuer's telephone number, including area code     (843) 497-7028
                                                       --------------

          Securities registered pursuant to section 12 (b) of the Act:

     Title of each class              Name of each exchange on which registered
            NONE                                        NONE
            ----                                        ----

          Securities registered pursuant to section 12 (g) of the Act:

                    COMMON STOCK, PAR VALUE $0.001 PER SHARE
                    ----------------------------------------
                                (Title of Class)

     As of September 15, 2003, the Company had 49,139,550 shares of common stock
issued and outstanding.

      Transitional Small Business Disclosure Format (check one).

                                              Yes [ ]  No [X]

<PAGE>

                          PART I: FINANCIAL INFORMATION

                                INTRODUCTORY NOTE

FORWARD-LOOKING STATEMENTS

     This  Form  10-QSB  contains   "forward-looking   statements"  relating  to
Altrimega Health Corporation  ("Altrimega") which represent  Altrimega's current
expectations or beliefs  including,  but not limited to,  statements  concerning
Altrimega's  operations,  performance,  financial condition and growth. For this
purpose, any statements contained in this Form 10-QSB that are not statements of
historical fact are forward-looking statements.  Without limiting the generality
of the  foregoing,  words  such as  "may",  "anticipation",  "intend",  "could",
"estimate",  or "continue" or the negative or other  comparable  terminology are
intended to  identify  forward-looking  statements.  These  statements  by their
nature  involve  substantial  risks and  uncertainties,  such as credit  losses,
dependence on management  and key personnel,  variability of quarterly  results,
and the ability of Altrimega to continue  its growth  strategy and  competition,
certain of which are  beyond  Altrimega's  control.  Should one or more of these
risks or uncertainties  materialize or should the underlying  assumptions  prove
incorrect,  actual  outcomes  and results  could  differ  materially  from those
indicated in the forward-looking statements.

     Any  forward-looking  statement  speaks  only as of the date on which  such
statement  is made,  and  Altrimega  undertakes  no  obligation  to  update  any
forward-looking statement or statements to reflect events or circumstances after
the date on  which  such  statement  is made or to  reflect  the  occurrence  of
unanticipated  events.  New  factors  emerge  from  time to  time  and it is not
possible for  management to predict all of such  factors,  nor can it assess the
impact of each such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements.

                                       1

<PAGE>

ITEM 1.   FINANCIAL STATEMENTS

                                       2

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEET
                                  JUNE 30, 2003

ASSETS
CURRENT ASSETS
  Cash                                                          $     50,953
  Inventory - real estate - residential units
   for sale - at cost                                              1,134,523
  Prepaid expenses                                                    10,841
                                                                ------------
   Total Current Assets                                            1,196,317

DEPOSITS                                                              35,000
                                                                ------------
ACCOUNT RECEIVABLE - related party                                    12,000
                                                                ------------

                                                                $  1,243,317
                                                                ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Notes payable - secured by residential units
   for sale                                                     $  1,230,178
  Accounts payable - related parties                                 260,740
  Accounts payable                                                    64,664
                                                                ------------
   Total Current Liabilities                                       1,555,582
                                                                ------------

MINORITY INTEREST                                                        400
                                                                ------------

STOCKHOLDERS'  DEFICIENCY
  Preferred stock
   10,000,000 shares authorized at $0.001 par value;
   1,000,000 shares issued and outstanding                             1,000
  Common stock
   50,000,000 shares authorized at $0.001 par value;
   48,139,950 shares issued and outstanding                           48,140
  Capital in excess of par value                                     171,304
  Deficit accumulated during the development stage                 (533,109)
                                                                ------------
   Total Stockholders' Deficiency                                  (312,665)
                                                                ------------

                                                                $  1,243,317
                                                                ============

   The accompanying notes are an integral part of these financial statements.

                                       3

<PAGE>

<TABLE>
<CAPTION>
                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
            FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2003 AND 2002

                                                     Three Months                 Six Months
                                               -------------------------    -------------------------
                                                Jun 30,        Jun 30,       Jun 30,       Jun 30,
                                                  2003           2002          2003          2002
                                               -----------    ----------    -----------   -----------
<S>                                            <C>            <C>           <C>           <C>
SALES                                              181,210             -    $   363,189   $         -

COST OF SALES                                      167,639             -        322,248             -
                                               -----------    ----------    -----------   -----------
  Gross Profit                                      13,571             -         40,941             -
                                               -----------    ----------    -----------   -----------
EXPENSES
  Consultants                                       45,000             -         90,000             -
  Administrative                                    41,878             -         46,002        10,895
                                               -----------    ----------    -----------   -----------
                                                    86,878             -        136,002        10,895
                                               -----------    ----------    -----------   -----------

NET LOSS - before minority interest               (73,307)             -       (95,061)      (10,895)

LESS MINORITY INTEREST                               1,118             -        (3,541)             -
                                               -----------    ----------    -----------   -----------

NET LOSS                                       $  (72,189)    $        -    $  (98,602)      (10,895)
                                               ===========    ==========    ===========   ===========
NET LOSS PER COMMON SHARE
  Basic and diluted                            $         -    $        -    $         -   $         -
                                               -----------    ----------    -----------   -----------
  AVERAGE  OUTSTANDING SHARES -
   (stated in 1,000's)
  Basic                                             46,140        41,807         45,140        41,807
                                               -----------    ----------    -----------   -----------
  Diluted                                          345,140       341,807        345,140       341,807
                                               -----------    ----------    -----------   -----------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                       4

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENT OF CASH FLOWS
                 FOR THE SIX MONTHS ENDED JUNE 30, 2003 AND 2002

                                                      Jun 30,       Jun 30,
                                                       2003           2002
                                                     -----------   -----------
CASH FLOWS FROM OPERATING ACTIVITIES

  Net loss                                           $  (98,602)   $  (10,895)

  Adjustments to reconcile net loss to net
   cash provided by operating activities

   Changes in Inventory                                  221,695             -

     Prepaid expenses                                    (4,441)             -

     Account receivable - related party                 (12,000)             -

     Accounts payable                                  (106,293)        10,895

   Minority interest                                       3,541             -

     Net Cash from Operations                              3,900             -
                                                     -----------   -----------

CASH FLOWS FROM INVESTING ACTIVITIES                           -             -
                                                     -----------   -----------

CASH FLOWS FROM FINANCING ACTIVITIES                           -             -
                                                     -----------   -----------

  Net Increase (decrease)  in Cash                         3,900             -

  Cash at Beginning of Period                             47,053             -
                                                     -----------   -----------

  Cash at End of Period                              $    50,953   $         -
                                                     ===========   ===========

   The accompanying notes are an integral part of these financial statements.

                                       5

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                          NOTES TO FINANCIAL STATEMENTS
                                  JUNE 30, 2003

1.  ORGANIZATION

The Company was incorporated  under the laws of the State of Nevada on September
8, 1998 with the name of Mega  International  Health Corporation with authorized
common stock of 50,000,000 shares with a par value of $0.001 and preferred stock
of  10,000,000  shares  with a par value of $0.001.  The terms of the  preferred
includes  conversion  rights,  at the  option of  stockholder,  of 300 shares of
common stock for each share of preferred.  On June 23, 1999 the name was changed
to Altrimega Health Corporation.

The Company was organized for the purpose of marketing  nutritional products and
during the year 2000 became  inactive.  During November 2002 the Company changed
its  purpose  to the  development  and sale of  residential  real  estate by the
acquisition of a residential real estate development company.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ACCOUNTING METHODS

The  Company  recognizes  income and  expenses  based on the  accrual  method of
accounting.

DIVIDEND POLICY

The Company has not adopted a policy regarding payment of dividends.

INCOME TAXES

On June 30, 2003 the Company had a net operating loss  carryforward of $668,729.
The tax benefit of  approximately  $200,617 from the loss carry forward has been
fully offset by a valuation reserve because the use of the future tax benefit is
doubtful,  since the Company has not been able to project a reliable  future net
operating profit. The loss carryover will expire starting in 2020 to 2024.

BASIC AND DILUTED NET INCOME (LOSS) PER SHARE

Basic net income  (loss) per share  amounts are  computed  based on the weighted
average  number of shares  actually  outstanding.  Diluted net income (loss) per
share amounts are computed  using the weighted  average  number of common shares
and common  equivalent  shares  outstanding  as if shares had been issued on the
exercise of the common share rights unless the exercise becomes antidilutive and
then only the basic per share amounts are shown in the report.

FINANCIAL INSTRUMENTS

The  carrying  amounts of  financial  instruments,  including  cash,  inventory,
prepaid expense,  account  receivable,  and accounts payable,  are considered by
management to be their estimated fair values.

                                       6

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                    NOTES TO FINANCIAL STATEMENTS (CONTINUED)
                                  JUNE 30, 2003

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

FINANCIAL AND CONCENTRATIONS RISK

The Company does not have any  concentration  or related  financial  credit risk
except for an account  receivable-related  party which is considered to be fully
collectable.

REVENUE RECOGNITION

Revenue  is  recognized  on the sale and  transfer  of title to the  residential
units.

STATEMENT OF CASH FLOWS

For the  purposes of the  statement  of cash flows,  the Company  considers  all
highly  liquid  investments  with a maturity of three  months or less to be cash
equivalents.

ADVERTISING AND MARKET DEVELOPMENT

The company expenses advertising and market development costs as incurred.

PRINCIPALS OF CONSOLIDATION

The  consolidated  financial  statements  shown  in  this  report  excludes  the
historical  operating  information of the parent before  September 30, 2002, and
includes the operating  information of the subsidiary,  Creative Holdings,  Inc.
from July 3, 2002  (date of  inception  of the  subsidiary),  and the  operating
information  of Sea  Garden  Funding  LLC from  November  2002  (the date of the
purchase of 80% of the LLC).

All intercompany transactions have been eliminated

ESTIMATES AND ASSUMPTIONS

Management uses estimates and assumptions in preparing  financial  statements in
accordance with accounting principles generally accepted in the United States of
America.  Those  estimates and  assumptions  affect the reported  amounts of the
assets and liabilities, the disclosure of contingent assets and liabilities, and
the reported revenues and expenses. Actual results could vary from the estimates
that were assumed in preparing these financial statements.

OTHER RECENT ACCOUNTING PRONOUNCEMENTS FINANCIAL AND CONCENTRATIONS RISK

The  Company  does not  expect  that the  adoption  of other  recent  accounting
pronouncements to have any material impact on its financial statements.

                                       7

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                    NOTES TO FINANCIAL STATEMENTS (CONTINUED)
                                  JUNE 30, 2003

3.  SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES

Officers-directors,  and their  controlled  entities,  have  acquired 36% of the
outstanding  stock of the Company,  after the conversion of the preferred shares
to common shares (note 1), and have made demand, no interest,  loans the Company
of $260,740.

The  Company  has made a demand,  no  interest  loan of $12,000 to the  minority
member of Sea Gardens Funding LLC.

The Company has an employment agreement with an officer, starting in 2003, which
provides  for an annual  salary of $100,000  with a 5%  increase  each year to a
maximum of $125,000, provided the Company has a profit in the previous year.

4.  CAPITAL STOCK

During 2002 the Company  issued  10,500,000  common shares at $.02 for services,
and the stock issued for the acquisition of the subsidiary outlined in note 5.

On March 19,  2003  2,000,000  common  shares of the  Company  were  issued as a
payment of $40,000 of accounts payable.

5.  ACQUISITION OF SUBSIDIARIES

On  September  30, 2002 the Company  acquired  all of the  outstanding  stock of
Creative Holding, Inc. (subsidiary),  by a stock for stock exchange in which the
former  stockholders of Creative received 13,619,950 common shares and 1,000,000
preferred  shares of the  Company,  and after the  conversion  of the  preferred
shares to common shares,  (note 1) represented 90.6% of the outstanding stock of
the  company.  For  reporting  purposes,  the  acquisition  was  treated  as  an
acquisition of the Company by Creative Holding, Inc. (reverse acquisition) and a
recapitalization of Creative Holding,  Inc. The historical  financial statements
prior to  September  30,  2002 are  those of  Creative  Holding,  Inc.  Creative
Holding,  Inc.  has no  significant  assets  and  therefore  no  good  will  was
recognized from the acquisition.  Creative Holdings,  Inc. was organized on July
3, 2002 in the state of South Carolina.

During  November 2002 the Company  acquired 80% of Sea Garden Funding LLC by the
assumption of certain  liabilities.  Sea Garden Funding LLC was organized in the
state of South Carolina on November 13, 2002 for the purpose of the  development
and sale of residential real estate.

6.  GOING CONCERN

The company will need additional working capital for its future planned activity
and to service  its debt which  raises  substantial  doubt  about its ability to
continue as a going concern.  Continuation  of the Company as a going concern is
dependent upon  obtaining  sufficient  working  capital to be successful in that
effort,  and the  management of the Company has  developed a strategy,  which it
believes will accomplish this objective,  through  additional  contributions  to
capital by related  parties,  additional  short term loans,  and equity funding,
which will enable the Company to operate for the coming year.

                                       8

<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                    NOTES TO FINANCIAL STATEMENTS (CONTINUED)
                                  JUNE 30, 2003

7.  COMMITMENTS

The Company has a consulting  agreement,  which provides for a quarterly payment
of $45,000.

                                       9

<PAGE>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

PLAN OF OPERATION

      Altrimega has entered the real estate development business with its merger
with Creative  Holdings,  Inc. of Myrtle Beach,  S.C.  Altrimega  will strive to
locate,  evaluate and proceed to finance and develop  multiple  projects located
primarily in the Myrtle Beach,  S.C.  area and the Carolinas  area of the United
States.  Management  believes  that these areas  provide the  population  growth
necessary to achieve profits from new construction  projects. For the last three
years,  Horry  County,  South  Carolina  has been one of the top  three  fastest
growing counties in the United States. In 1997, Horry County showed a population
of only  180,000.  Based on current  projections  and the 2000 census data,  the
county will have a permanent  population of 500,000 by next year.  The principal
industries  of the area are  tourism  related.  Myrtle  Beach  is  considered  a
drive-in  market,  where  tourists  will drive their cars rather than fly to the
destination.  The tourism  industry in Myrtle Beach has developed three seasons,
spring golf,  summer  beach  vacations  and fall golf.  The spring and fall golf
seasons bring approximately  150,000 visitors per week to play on the areas over
100 golf courses. The summer vacation season brings in approximately 400,000 per
week. The average tourist stay is one week.

      Altrimega's  business  strategy  includes  a focus on  interval  ownership
properties  that cater to this major  tourism  industry.  As well,  we intend to
develop  projects in the medium  price  ranges for the areas  permanent  service
industry  population.  Management  will  attempt to seek out  low-risk  projects
throughout the Carolinas that do not require large financing commitments.

SEA GARDEN TOWN HOME COMMUNITY IN NORTH MYRTLE BEACH, SOUTH CAROLINA

      Altrimega  has  exercised  Creative  Holdings'  option and acquired an 80%
interest in Sea Garden Funding, LLC, the owner and developer of the remaining 59
units in a 175 unit,  2  bedroom,  2 bath town home  community  approximately  3
blocks  from the  Atlantic  shoreline.  Sea Garden  Funding  purchased  the real
property  from Sea  Garden,  LLC on October 21, 2002 for the payment of $210,000
and the  assumption of  $1,071,344.66  in mortgages on the real property held by
Horry County State Bank. The development  consists of buildings that have either
4 or 5 units per building.  The  remaining  20% interest in Sea Garden  Funding,
LLC, is owned by an unaffiliated  party. The community currently consists of 116
sold units.  This is Altrimega's  first revenue  producing real estate  project.
During the first two quarters of 2003, this project produced revenue of $363,189
with gross profit of $40,941.

RESULTS OF OPERATIONS

      We are a development stage company and have had limited  operations during
the six months ended June 30, 2003 and during the fiscal year ended December 31,
2002. Since our inception  (September 8, 1998 through June 30, 2003), we have an
accumulated  deficit of $533,109 and we have had limited operating capital. As a
result,  the report of our auditor for the fiscal year ended  December  31, 2002
contains a going concern  qualification,  which states that  Altrimega will need
additional  capital for its future  planned  activities  and to service its debt
which  raises  substantial  concern  about our  ability to  continue  as a going
concern. Our continuation as a going concern is dependent on our ability to meet
our obligations and obtain  additional debt or equity  financing  required until
our  current and  proposed  real estate  projects  are under way and  generating
earnings.  Until such time as these  projects are generating  earnings,  we have
taken the following steps to revise our operating and financial  requirements in
an effort to enable us to continue in existence:

      o    We have reduced administrative expenses to a minimum by consolidating
           management  responsibilities  to our  president  and chief  executive
           officer.

      o    We intend to seek either equity or further debt funding.

      o    We will attempt to obtain the professional  services of third-parties
           through favorable  financing  arrangements or payment by the issuance
           of our common stock.

      We believe that the foregoing  plan will enable us to generate  sufficient
funds to continue its operations for the next twelve months.

                                       10

<PAGE>

      For the three  months  ended  June 30,  2003,  Altrimega  had  revenue  of
$181,210,  consisting  of the  sale of 2 units  in the Sea  Garden  Funding  LLC
project.

      For the three months ended June 30, 2003,  our cost of sales was $167,639,
compared  to $0 for the  comparable  period in the prior year.  The  increase of
$167,639  was the  result  of  sales of 2 units at the Sea  Garden  Funding  LLC
project.  The sale of these units  resulted in a gross profit of $13,571 for the
three  months ended June 30,  2003,  compared  with a gross profit of $0 for the
comparable period in the prior year.

      For the three months ended June 30, 2003,  Altrimega had total expenses of
$86,878,  consisting of $45,000 in consultant fees and $41,878 in administrative
expenses.  During the  comparable  period in the prior  year,  Altrimega  had no
expenses.  The  increase in total  expenses of $86,878  during the three  months
ended June 30, 2003 was primarily due to our increased  operations  with respect
to the Sea Garden Funding LLC project.

      For the three  months  ended June 30,  2003,  Altrimega  had a net loss of
$72,189 as compared to a net loss of $0 for the  comparable  period in the prior
year. The increase in our net loss was primarily  attributable to accounting and
legal fees  incurred  in the  quarter.  While we had  revenues  during the first
quarter of 2003, and no revenues  during the first quarter of 2002, our net loss
increased  by $6,508 based on our  increase in total  expenses  during the first
quarter of 2003.

      For the six  months  ended  June  30,  2003,  Altrimega  had  revenues  of
$363,189,  consisting  of the  sale of 4 units  in the Sea  Garden  Funding  LLC
project.

      For the six months  ended June 30, 2003,  our cost of sales was  $322,248,
compared  to $0 for the  comparable  period in the prior year.  The  increase of
$322,248  was the  result  of  sales of 4 units at the Sea  Garden  Funding  LLC
project.  The sale of these units  resulted in a gross profit of $40,941 for the
six  months  ended June 30,  2003,  compared  with a gross  profit of $0 for the
comparable period in the prior year.

      For the six months ended June 30, 2003,  Altrimega  had total  expenses of
$136,002,  as compared to $10,895 for the  comparable  period in the prior year.
For the six months  ended  June 30,  2003,  Altrimega's  expenses  consisted  of
$90,000 in consulting fees and $46,002 in administrative  expenses,  as compared
to $10,895 in administrative  expenses during the comparable period in the prior
year. The increase in total expenses of $125,107 or 1,148.3%,  was primarily due
to accounting and legal fees incurred in the six months ended June 30, 2003.

      For the six  months  ended  June  30,  2003,  Altrimega  had a net loss of
$98,602,  as compared to a net loss of $10,895 for the comparable  period in the
prior year.  While we had revenues during the six months ended June 30, 2003 and
no revenues during the six months ended June 30, 2003, our net loss increased by
$87,707  based on our  increase for total  expenses  during the six months ended
June 30, 2003.

LIQUIDITY AND CAPITAL RESOURCES

      We had  limited  operations  and no income  during the  fiscal  year ended
December  31,  2002.  We had limited  operations  during the first six months of
2003.  Our shortfall in working  capital has been met through  advances from our
president,  John Gandy,  and other  shareholders  who have advanced funds to pay
expenses incurred by the Company from time to time. At no time during the fiscal
year 2002 or the six  months  ended  June 30,  2003 did these  short  term loans
exceed  $60,000.  For fiscal year 2003, we anticipate that we will need $300,000
to  continue to fund basic  operations,  in  addition  to funding  necessary  to
acquire an develop real estate projects.

      For the six months ended June 30, 2003,  we had revenues of $363,189 and a
net loss of $98,602.  On June 30,  2003,  we had cash on hand of $50,953,  total
assets of $1,243,317,  total  liabilities of $1,555,582,  and a working  capital
deficit of $359,265. Our accumulated deficit on June 30, 2003 was $533,109.

      We  anticipate  that we will require  significant  capital to maintain our
corporate  viability  and execute our plan to develop real estate  projects.  We
anticipate  necessary  funds  will  most  likely  be  provided  by our  existing
shareholders,  our officers and directors and outside investors. We will require
significant  loan  guarantees  to  acquire  properties  for  development  and to
complete  construction  on  Creative  Holdings'  planned  projects.  We  will be
required  to pledge  equity in the  Company to induce  individuals,  officers or
directors or other shareholders to guarantee our loans when necessary.

      Altrimega's  financial  statements  have been  prepared on a going concern
basis  that  contemplates  the  realization  of  assets  and the  settlement  of
liabilities  and  commitments  in the  normal  course  of  business.  Management
recognizes  that  Altrimega must generate  additional  resources to enable it to

                                       11

<PAGE>

continue  operations.  Management  is  planning  to  obtain  additional  capital
principally  through the sale of equity and debt securities.  The realization of
assets and  satisfaction  of  liabilities  in the normal  course of  business is
dependent  upon  Altrimega  obtaining  additional  equity  or debt  capital  and
ultimately obtaining profitable operations.  However, no assurances can be given
that  Altrimega  will be  successful  in these  activities.  Should any of these
events not occur, the  accompanying  consolidated  financial  statements will be
materially affected.

      Altrimega is at present meeting its current  obligations  from its monthly
cash flows from investor capital and loans from related parties. However, due to
insufficient  cash  generated  from  operations,  Altrimega  currently  does not
internally  generated  cash  sufficient to pay all of its incurred  expenses and
other liabilities.  As a result,  Altrimega is dependent on investor capital and
loans to meet its expenses and obligations.  Although investor funds and related
party loans have allowed  Altrimega to meet its  obligations in the recent past,
there can be no assurances that  Altrimega's  present methods of generating cash
flow will be sufficient to meet future obligations.

      Cash from operating  activities was $3,900 for the six months period ended
June 30, 2003. The cash was mainly from changes in inventory of $221,695.  There
was no cash from investing  activities during the six months ended June 30, 2003
and $3,900 net increase in cash from financing  activities during the six months
ended June 30, 2003.

      From time to time, Altrimega may evaluate potential acquisitions involving
complementary businesses,  content,  products or technologies.  Altrimega has no
present  agreements  or  understanding  with  respect  to any such  acquisition.
Altrimega's future capital  requirements will depend on many factors,  including
an increase in Altrimega's real estate projects, and other factors including the
results of future operations.

ITEM 3.   CONTROLS AND PROCEDURES

      (a) EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

      Within  90 days  prior  to the  date of this  Report,  we  carried  out an
evaluation,  under  the  supervision  and with the  participation  of our  Chief
Executive  Officer and Chief  Financial  Officer,  of the  effectiveness  of the
design and operation of our disclosure  controls and  procedures.  Based on this
evaluation,  our Chief Executive  Officer and Chief Financial  Officer concluded
that our disclosure  controls and  procedures  are effective in timely  alerting
them to material  information  required to be included in our  periodic  reports
that are filed with the Securities and Exchange  Commission.  It should be noted
that the  design  of any  system  of  controls  is based  in part  upon  certain
assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving  its stated goals under all  potential
future  conditions,  regardless  of how remote.  In  addition,  we reviewed  our
internal  controls,  and there have been no significant  changes in our internal
controls or in other  factors that could  significantly  affect  those  controls
subsequent to the date of their last valuation.

      (b) CHANGES IN INTERNAL CONTROLS:

      There were no significant changes in the Altrimega's  internal controls or
in other  factors  that could  significantly  affect these  controls  during the
quarter  covered by this report or from the end of the  reporting  period to the
date of this Form 10-QSB.

                                       12

<PAGE>

                           PART II: OTHER INFORMATION

ITEM 1.   LEGAL PROCEDURES

      None.

ITEM 2.   CHANGES IN SECURITIES

      (a)  Effective  September  30, 2002,  Altrimega  issued Series A Preferred
Stock.  The rights of holders of Series A  Preferred  Stock are set forth in the
Certificate of Designation  filed as an Exhibit 4.01 to Altrimega's Form 10-KSB,
filed on May 20, 2003. Each share of the series is convertible, at the option of
the holder, into three hundred shares of common stock.

      (b) None.

      (c) None.

      (d) None.

ITEM 3.   DEFAULTS UPON SENIOR SECURITIES

      None.

ITEM 4.   SUBMISSION OF MATTERS TO BE A VOTE OF SECURITY HOLDERS

      None

ITEM 5.   OTHER INFORMATION

      None.

ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K

      (a)(1)  EXHIBITS.  The  following  exhibits  are  included as part of this
report:

<TABLE>
<CAPTION>
                  SEC REFERENCE
EXHIBIT NUMBER    NUMBER             TITLE OF DOCUMENT                LOCATION
--------------    -------------      -----------------------------    -------------------------
<S>               <C>                <C>                              <C>
2.01              2                  SHARE EXCHANGE AGREEMENT         Incorporated by reference
                                       among Altrimega Health           to the Company's report
                                       Corporation, Creative            on Form 8-K, dated
                                       Holdings, Inc. and the           October 2, 2002
                                       Shareholders of Creative
                                       Holdings, Inc., dated as of
                                       September 2, 2002

4.01              4                  CERTIFICATE OF DESIGNATION AS    Incorporated by reference
                                       OF SEPTEMBER 30, 2002            to Exhibit 4.01 to the
                                                                        Company's Form 10-KSB
                                                                        filed on May 20, 2003
</TABLE>

      (b) REPORTS ON FORM 8-K. None.

                                       13

<PAGE>

                                   SIGNATURES

      Pursuant  to the  requirements  of Section  13 or 15(d) of the  Securities
Exchange  Act of 1934,  the  Company has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

September 23, 2003                      ALTRIMEGA HEALTH CORPORATION


                                        By:            /s/ JOHN GANDY
                                           -------------------------------------
                                                       John Gandy,
                                                       Chief Executive Officer
                                                         and Director



                                        By:            /s/ RON HENDRIX
                                           -------------------------------------
                                                       Ron Hendrix,
                                                       Chief Financial Officer
                                                         and Secretary

                                       14

<PAGE>

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly  Report of Altrimega  Health  Corporation
(the "Company") on Form 10-QSB for the quarter ended June 30, 2003 as filed with
the Securities and Exchange  Commission on the date hereof (the "Report"),  each
of the undersigned,  in the capacities and on the dates indicated below,  hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:

      1.   The Report fully complies with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      2.   The  information  contained  in the Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of  operation of the
Company.


Date:          September 23, 2003       By:            /s/ JOHN GANDY
                                           -------------------------------------
                                                       John Gandy
                                                       Chief Executive Officer



                                        By:            /s/ RON HENDRIX
                                           -------------------------------------
                                                       Ron Hendrix
                                                       Chief Financial Officer

                                       A-1

<PAGE>

                              OFFICER'S CERTIFICATE
                             PURSUANT TO SECTION 302

                                  CERTIFICATION


      I, John Gandy, certify that:

      1.   I have  reviewed  this  quarterly  report on Form 10-QSB of Altrimega
Health Corporation.;

      2.   Based on my  knowledge,  this  quarterly  report does not contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report;

      3.   Based on my knowledge, the financial statements,  and other financial
information  included in this quarterly  report,  fairly present in all material
respects  the  financial  condition,  results  of  operations  and cash flows of
Registrant as of, and for, the periods presented in this quarterly report;

      4.   The Registrant's other certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for Registrant and we have:

      a)   Designed  such  disclosure  controls  and  procedures  to ensure that
           material   information   relating  to   Registrant,   including   its
           consolidated subsidiaries, is made known to us by others within those
           entities,  particularly  during the  period in which  this  quarterly
           report is being prepared;

      b)   Evaluated the effectiveness of Registrant's  disclosure  controls and
           procedures  as of a date  within 90 days prior to the filing  date of
           this quarterly report (the "Evaluation Date"); and

      c)   Presented  in  this  quarterly  report  our  conclusions   about  the
           effectiveness of the disclosure  controls and procedures based on our
           evaluation as of the Evaluation Date;

      5.   The  Registrant's  other  certifying  officers and I have  disclosed,
based on our most recent  evaluation,  to  Registrant's  auditors  and the audit
committee  of  Registrant's  board  of  directors  (or  persons  performing  the
equivalent function):

      a)   All  significant  deficiencies in the design or operation of internal
           controls which could adversely affect Registrant's ability to record,
           process,  summarize and report financial data and have identified for
           Registrant's  auditors any material  weaknesses in internal controls;
           and

      b)   Any fraud, whether or not material, that involves management or other
           employees  who  have a  significant  role  in  Registrant's  internal
           controls; and

      6.   The Registrant's  other  certifying  officers and I have indicated in
this quarterly report whether or not there were significant  changes in internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:          September 23, 2003       By:            /s/ JOHN GANDY
                                            ------------------------------------
                                                       John Gandy
                                                       Chief Executive Officer

                                       B-1

<PAGE>

                              OFFICER'S CERTIFICATE
                             PURSUANT TO SECTION 302

                                  CERTIFICATION


      I, Ron Hendrix, certify that:

      1.   I have reviewed this quarterly report on Form 10-QSB of Altrimega

Health Corporation;

      2.   Based on   my knowledge,  this quarterly  report does not contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report;

      3.   Based on my knowledge, the financial statements,  and other financial
information  included in this quarterly  report,  fairly present in all material
respects  the  financial  condition,  results  of  operations  and cash flows of
Registrant as of, and for, the periods presented in this quarterly report;

      4.   The Registrant's other certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for Registrant and we have:

      a)   Designed  such  disclosure  controls  and  procedures  to ensure that
           material   information   relating  to   Registrant,   including   its
           consolidated subsidiaries, is made known to us by others within those
           entities,  particularly  during the  period in which  this  quarterly
           report is being prepared;

      b)   Evaluated the effectiveness of Registrant's  disclosure  controls and
           procedures  as of a date  within 90 days prior to the filing  date of
           this quarterly report (the "Evaluation Date"); and

      c)   Presented  in  this  quarterly  report  our  conclusions   about  the
           effectiveness of the disclosure  controls and procedures based on our
           evaluation as of the Evaluation Date;

      5.   The  Registrant's  other  certifying  officers and I have  disclosed,
based on our most recent  evaluation,  to  Registrant's  auditors  and the audit
committee  of  Registrant's  board  of  directors  (or  persons  performing  the
equivalent function):

      a)   All  significant  deficiencies in the design or operation of internal
           controls which could adversely affect Registrant's ability to record,
           process,  summarize and report financial data and have identified for
           Registrant's  auditors any material  weaknesses in internal controls;
           and

      b)   Any fraud, whether or not material, that involves management or other
           employees  who  have a  significant  role  in  Registrant's  internal
           controls; and

      6.   The Registrant's  other  certifying  officers and I have indicated in
this quarterly report whether or not there were significant  changes in internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:          September 23, 2003       By:            /s/ RON HENDRIX
                                            ------------------------------------
                                                       Ron Hendrix
                                                       Chief Financial Officer

                                       C-1